Arcus Biosciences
RCUS
RCUS
130 hedge funds and large institutions have $1.24B invested in Arcus Biosciences in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 45 increasing their positions, 46 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% less funds holding
Funds holding: 148 → 130 (-18)
38% less call options, than puts
Call options by funds: $7.63M | Put options by funds: $12.3M
56% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 32
Holders
130
Holding in Top 10
6
Calls
$7.63M
Puts
$12.3M
Top Buyers
| 1 | +$31.3M | |
| 2 | +$25.3M | |
| 3 | +$23.5M | |
| 4 |
BlackRock
New York
|
+$17.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$14.3M |
Top Sellers
| 1 | -$40.1M | |
| 2 | -$29.4M | |
| 3 | -$15.1M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$10.2M |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$6.64M |